{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T22:30:38Z","timestamp":1765319438461,"version":"3.46.0"},"reference-count":14,"publisher":"BMJ","issue":"6395","license":[{"start":{"date-parts":[[1983,9,17]],"date-time":"1983-09-17T00:00:00Z","timestamp":432604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J (Clin Res Ed)"],"published-print":{"date-parts":[[1983,9,17]]},"abstract":"<jats:p>Treatment of hypoparathyroidism usually requires the use of pharmacological doses of parent vitamin D or near physiological amounts of the hydroxylated metabolites, calcitriol or alphacalcidol. Vitamin D intoxication and hypercalcaemia may be a problem but can be minimised by the use of small doses of vitamin D or its metabolites combined with large amounts of oral calcium. The response to treatment can be easily monitored by measuring serum and urinary calcium and creatinine concentrations. This allows the derivation of two simple indices reflecting calcium load presented to the kidney (calcium excretion in mmol\/l glomerular filtrate) and renal tubular calcium reabsorption (TmCa\/GFR). These can be used to predict the requirement of calcium supplements and also identify those patients at particular risk of hypercalcaemia.<\/jats:p>","DOI":"10.1136\/bmj.287.6395.781","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T11:00:59Z","timestamp":1238670059000},"page":"781-784","source":"Crossref","is-referenced-by-count":2,"title":["Renal handling of calcium in hypoparathyroidism."],"prefix":"10.1136","volume":"287","author":[{"given":"G H","family":"Newman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D J","family":"Hosking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1983,9,17]]},"reference":[{"issue":"151","key":"ref_1","article-title":"The assay of 1,25 dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels","volume":"5","author":"Haussler, M.R.; Baylink, D.J.; Hughes, M.R.","year":"1976","unstructured":"Haussler MR, Baylink DJ, Hughes MR, et al. The assay of 1,25 dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels. Clin Endocrinol 1976;5 suppl:151S-165S.","journal-title":"Clin Endocrinol"},{"key":"ref_2","first-page":"257","article-title":"Vitamin D; mode of action and biomedical applications","volume":"32","author":"Haussler, M.R.","year":"1974","unstructured":"Haussler MR. Vitamin D; mode of action and biomedical applications. Nurr Rev 1974;32:257-66.","journal-title":"Nurr Rev"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM197711032971804","article-title":"Basic and clinical concepts related to vitamin D metabolism and action","volume":"297","author":"Haussler, M.R.; McCain, T.A.","year":"1977","unstructured":"Haussler MR, McCain TA. Basic and clinical concepts related to vitamin D metabolism and action. N Engl3r Med 1977;297:974-83.","journal-title":"N Engl3r Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0002-9343(74)90765-7","article-title":"The therapeutic approach to hypoparathyroidism","volume":"57","author":"Avioli, L.V.","year":"1974","unstructured":"Avioli LV. The therapeutic approach to hypoparathyroidism. Am J Med 1974;57:34-42.","journal-title":"Am J Med"},{"key":"ref_5","first-page":"55","article-title":"1,25 Dihydroxycholecalciferol in hypoparathyroidism","volume":"i:","author":"Davies, M.; Taylor, C.M.; Hill, L.F.; Stanbury, S.W.","year":"1977","unstructured":"Davies M, Taylor CM, Hill LF, Stanbury SW. 1,25 Dihydroxycholecalciferol in hypoparathyroidism. Lancet 1977;i:55-9.","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(70)90204-7","article-title":"Vitamin D treatment in hypoparathyroidism","volume":"ii:","author":"Parfitt, A.M.","year":"1970","unstructured":"Parfitt AM. Vitamin D treatment in hypoparathyroidism. Lancet 1970;ii: 614-5.","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0003-9861(76)90506-3","article-title":"Intestinal calcium transport: parathyroid hormone and adaptation to dietary calcium","volume":"175","author":"Ribvich, M.L.; Deluca, H.F.","year":"1976","unstructured":"Ribvich ML, Deluca HF. Intestinal calcium transport: parathyroid hormone and adaptation to dietary calcium. Arch Biochem Biophys 1976;175:256-61.","journal-title":"Arch Biochem Biophys"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0140-6736(69)91353-1","article-title":"Relation between serum and urinary calcium with particular reference to parathyroid activity","volume":"i:","author":"Peacock, M.; Robertson, W.G.","year":"1969","unstructured":"Peacock M, Robertson WG. Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet 1969;i:384-6.","journal-title":"Lancet"},{"issue":"81","key":"ref_9","first-page":"2","article-title":"Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1-hydroxylated derivatives","volume":"78","author":"Kanis, J.A.; Russell, R.G.G.","year":"1977","unstructured":"Kanis JA, Russell RGG. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1-hydroxylated derivatives. Br MedJ 1977;i:78-81. 2\"1 Breslau NA, Pak CYC. Hypoparathyroidism. Metabolismi 1979;28:126176.","journal-title":"Br MedJ"},{"key":"ref_10","first-page":"186","article-title":"Plasmacalcium and plasma magnesium homeostasis","volume-title":"phosphate and magnesiuxm ?netabolismn","author":"Nordin, B.E.C.","year":"1976","unstructured":"Nordin BEC. Plasmacalcium and plasma magnesium homeostasis. In: Nordin BEC, ed. Calcium phosphate and magnesiuxm ?netabolismn. Edinburgh: Churchill Livingstone, 1976:186-208."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.3.5926.310","article-title":"Effects of therapy on rate of absorption of calcium from gut in disorders of calcium homeostasis","volume":"-iii:","author":"Reeve, J.; Hesp, R.; Veall, N.","year":"1974","unstructured":"Reeve J, Hesp R, Veall N. Effects of therapy on rate of absorption of calcium from gut in disorders of calcium homeostasis. Br Med ] 1974 -iii: 310-3.","journal-title":"Br Med"},{"key":"ref_12","first-page":"373","article-title":"Evidence for a direct action of cholecalciferol and 25 hydroxycholecalciferol on the renal transport","volume-title":"of phosphate, sodium and calcium.7Clin Invest","volume":"51","author":"Puschett, J.B.; Moranz, J.; Kurnick, W.","year":"1972","unstructured":"Puschett JB, Moranz J, Kurnick W. Evidence for a direct action of cholecalciferol and 25 hydroxycholecalciferol on the renal transport of phosphate, sodium and calcium.7Clin Invest 1972;51:373-85."},{"key":"ref_13","first-page":"379","article-title":"The acute renal tubular effects","volume-title":"of 1,25 dihydroxycholecalciferol. Proc Soc Exp Biol Med","volume":"141","author":"Puschett, J.B.; Fernandex, P.C.; Boyle, I.T.; Gray, R.W.; Omdahl, I.L.; Deluca, H.F.","year":"1972","unstructured":"Puschett JB, Fernandex PC, Boyle IT, Gray RW, Omdahl IL, Deluca HF. The acute renal tubular effects of 1,25 dihydroxycholecalciferol. Proc Soc Exp Biol Med 1972;141:379-84."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00003086-196700520-00022","article-title":"Membrane transfer of calcium","volume":"52","author":"Borle, A.B.","year":"1967","unstructured":"Borle AB. Membrane transfer of calcium. C(lin Orthop 1967;52:267-91.","journal-title":"C(lin Orthop"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.287.6395.781","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.287.6395.781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T22:29:41Z","timestamp":1765319381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.287.6395.781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,9,17]]},"references-count":14,"journal-issue":{"issue":"6395","published-online":{"date-parts":[[1983,9,17]]},"published-print":{"date-parts":[[1983,9,17]]}},"alternative-id":["10.1136\/bmj.287.6395.781"],"URL":"https:\/\/doi.org\/10.1136\/bmj.287.6395.781","relation":{},"ISSN":["0007-1447","1468-5833"],"issn-type":[{"type":"print","value":"0007-1447"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1983,9,17]]}}}